Gentium’s Liver Disease Drug Falls Short in Trial
Italian drugmaker Gentium’s liver disease treatment defibrotide has failed to meet efficacy endpoints in a Phase III trial, the company says.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.